Skip to main content
Signal8

Juvenescence Ltd

SEC insider (Form 3/4/5 filer). CIK 0001724307. 10% Owner at Serina Therapeutics, Inc. (SER). 5 reported Form 4/5 transactions since Sep 2024; latest on Jan 31, 2025. Located in RAMSEY, Y8.

Companies Juvenescence Ltd has filed insider reports for

  • Serina Therapeutics, Inc. (SER): 10% Owner
Juvenescence Ltd profile photo

Juvenescence Ltd

CIK: 0001724307

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (20.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Serina Therapeutics, Inc. logo
SER

Serina Therapeutics, Inc.

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Serina Therapeutics, Inc. logo
    SER

    Serina Therapeutics, Inc.

    Jan 31, 2025
    Award
    Indirect
    500K shares at avg. $10.00$5.0M
  • Serina Therapeutics, Inc. logo
    SER

    Serina Therapeutics, Inc.

    Nov 27, 2024
    Award
    Indirect
    500K shares at avg. $10.00$5.0M
  • Serina Therapeutics, Inc. logo
    SER

    Serina Therapeutics, Inc.

    Nov 27, 2024
    Disposition

    Warrants

    Indirect
    755.7K shares-
  • Serina Therapeutics, Inc. logo
    SER

    Serina Therapeutics, Inc.

    Jun 6, 2024
    Exercise
    Indirect
    377.9K shares at avg. $13.20$5.0M
  • Serina Therapeutics, Inc. logo
    SER

    Serina Therapeutics, Inc.

    Jun 6, 2024
    Award

    Warrants

    Indirect
    377.9K shares-

1-5 of 5